EXPRESSION OF MESSENGER-RNA FOR SOMATOSTATIN RECEPTOR (SSTR) TYPE-2 AND TYPE-5 IN INDIVIDUAL, RAT PITUITARY-CELLS - A DOUBLE-LABELING IN-SITU HYBRIDIZATION ANALYSIS

被引:96
作者
DAY, R
DONG, WJ
PANETTA, R
KRAICER, J
GREENWOOD, MT
PATEL, YC
机构
[1] MCGILL UNIV, ROYAL VICTORIA HOSP, DEPT MED, FRASER LABS, MONTREAL, PQ H3A 1A1, CANADA
[2] MCGILL UNIV, ROYAL VICTORIA HOSP, DEPT NEUROL & NEUROSURG, MONTREAL, PQ H3A 1A1, CANADA
[3] MONTREAL NEUROL INST, MONTREAL, PQ, CANADA
[4] CLIN RES INST MONTREAL, MONTREAL, PQ H2W 1R7, CANADA
[5] UNIV WESTERN ONTARIO, LONDON, ON N6A 3K7, CANADA
关键词
D O I
10.1210/en.136.11.5232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To characterize cell specific expression of sstr subtypes in the pituitary we have analyzed mRNA for sstr1-5 in rat pituitary somatotrophs by reverse transcriptase polymerase chain reaction and determined the pattern and level of expression of mRNA for sstr subtypes 2 and 5 in individual pituitary cell subpopulations by double label in situ hybridization. Purified somatotrophs expressed mRNA for all 5 sstrs. In situ hybridization analysis revealed sstr5 mRNA in 70% of somatotrophs, 57% of thyrotrophs, 38% of corticotrophs, 33% of lactotrophs, and 21% of gonadotrophs. mRNA for sstr2 occurred in 40% of somatotrophs, 36% of thyrotrophs, 26% of lactotrophs, 3% of corticotrophs, and 8% of gonadotrophs. Not only were more cells positive for sstr5 mRNA but the average number of autoradiographic grains/cell was also higher for sstr5 than sstr2. These results show expression of multiple sstr genes in individual pituitary cells. mRNA for sstr2 and 5 occur in each of the 5 major pituitary cell subsets, sstr5 mRNA being more widely and more abundantly expressed than sstr2.
引用
收藏
页码:5232 / 5235
页数:4
相关论文
共 16 条
  • [1] TISSUE DISTRIBUTION OF SOMATOSTATIN RECEPTOR SUBTYPE MESSENGER-RIBONUCLEIC-ACID IN THE RAT
    BRUNO, JF
    XU, Y
    SONG, JF
    BERELOWITZ, M
    [J]. ENDOCRINOLOGY, 1993, 133 (06) : 2561 - 2567
  • [2] SOMATOSTATIN REGULATES SOMATOSTATIN RECEPTOR SUBTYPE MESSENGER-RNA EXPRESSION IN GH(3) CELLS
    BRUNO, JF
    XU, Y
    BERELOWITZ, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) : 1738 - 1743
  • [3] MOLECULAR PHARMACOLOGY OF SOMATOSTATIN-RECEPTOR SUBTYPES
    BRUNS, C
    WECKBECKER, G
    RAULF, F
    KAUPMANN, K
    SCHOEFFTER, P
    HOYER, D
    LUBBERT, H
    [J]. MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 138 - 146
  • [4] CHARACTERISTICS OF INTERACTION BETWEEN THYROTROPIN-RELEASING-HORMONE AND SOMATOSTATIN FOR THYROTROPIN AND PROLACTIN-RELEASE
    DROUIN, J
    DELEAN, A
    RAINVILLE, D
    LACHANCE, R
    LABRIE, F
    [J]. ENDOCRINOLOGY, 1976, 98 (02) : 514 - 521
  • [5] HETEROGENEOUS EXPRESSION OF 2 SOMATOSTATIN RECEPTOR SUBTYPES IN PITUITARY-TUMORS
    GREENMAN, Y
    MELMED, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) : 398 - 403
  • [7] CLONAL ORIGIN OF PITUITARY-ADENOMAS
    HERMAN, V
    FAGIN, J
    GONSKY, R
    KOVACS, K
    MELMED, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (06) : 1427 - 1433
  • [8] EXPRESSION CLONING OF A RAT-BRAIN SOMATOSTATIN RECEPTOR CDNA
    KLUXEN, FW
    BRUNS, C
    LUBBERT, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4618 - 4622
  • [10] THE ROLE OF SOMATOSTATIN AND ITS ANALOGS IN THE DIAGNOSIS AND TREATMENT OF TUMORS
    LAMBERTS, SWJ
    KRENNING, EP
    REUBI, JC
    [J]. ENDOCRINE REVIEWS, 1991, 12 (04) : 450 - 482